Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i.

Diabetes Obes Metab · 2021 · PMC8518913 · PMID 34132018

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Correlation analysis showed a trend for greater body weight reduction in patients with higher baseline BMI in both arms (r = 0.14 for liraglutide and r = 0.26 for placebo) (Figure 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.